Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00172523
Status:
UNKNOWN
Last Update Posted:
2005-09-15
First Post:
2005-09-12
Brief Title:
Metabolic Disorders in Polycystic Ovarian Syndrome
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2004-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to elucidate the significance of adipocytokine in women with PCOS among adiposity hyperandrogenism and insulin resistance
Detailed Description:
Polycystic ovary syndrome PCOS is the most common endocrinopathy in women of reproductive age with a probable prevalence of 5 to 10 PCOS is characterized by chronic anovulation menstrual irregularities evidence of hyperandrogenism either clinical manifested as hirsutism acne male pattern balding or biochemical manifested by elevated serum adrenal andor ovarian androgen concentration Fifty percent of all patients with PCOS are obese and the presence of obesity affects the clinical manifestations of PCOS The underlying pathogenic mechanisms appear to involve insulin resistance and hyperinsulinemia the magnitude of which is greater in obese than in non-obese women with PCOS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None